P |
2019-02-14 |
2019-02-19 17:06:08.0 |
GENOCEA BIOSCIENCES, INC. |
GNCA |
MOTT DAVID M |
10% owner |
9,948,270 |
$0.47 |
$4,688,620.00 |
3.49483E7 |
|
view |
P |
2018-09-07 |
2018-09-10 16:50:03.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
1.2E7 |
$1.67 |
$2.00004E7 |
1.2E7 |
|
view |
P |
2018-09-07 |
2018-09-10 16:50:03.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
3,000,000 |
$1.67 |
$5,000,100.00 |
8.2978704E7 |
|
view |
P |
2018-03-27 |
2018-03-28 17:14:19.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
6,000,000 |
$1.92 |
$1.15002E7 |
7.9978704E7 |
|
view |
P |
2018-03-26 |
2018-03-28 17:14:19.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
571,164 |
$1.90 |
$1,087,550.00 |
7.3978704E7 |
|
view |
P |
2018-03-21 |
2018-03-23 18:34:03.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
104,844 |
$1.81 |
$189,820.00 |
7.22438E7 |
|
view |
P |
2018-03-22 |
2018-03-23 18:34:03.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
869,574 |
$1.90 |
$1,655,670.00 |
7.31134E7 |
|
view |
P |
2018-03-23 |
2018-03-23 18:34:03.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
294,090 |
$1.95 |
$572,358.00 |
7.3407504E7 |
|
view |
P |
2017-10-10 |
2017-10-10 16:35:55.0 |
RHYTHM PHARMACEUTICALS, INC. |
RYTM |
MOTT DAVID M |
10% owner |
550,000 |
$17.00 |
$9,350,000.00 |
4,909,960 |
|
view |
P |
2017-07-03 |
2017-07-06 17:19:29.0 |
Mersana Therapeutics, Inc. |
MRSN |
MOTT DAVID M |
director 10% owner |
1,000,000 |
$15.00 |
$1.5E7 |
8,140,140 |
|
view |
P |
2017-03-27 |
2017-03-28 16:26:11.0 |
Adaptimmune Therapeutics PLC |
ADAP |
MOTT DAVID M |
director 10% owner |
1.287E7 |
$0.70 |
$9,009,000.00 |
7.2139E7 |
N/A |
view |
P |
2016-11-29 |
2016-11-29 17:57:52.0 |
Tracon Pharmaceuticals, Inc. |
TCON |
MOTT DAVID M |
10% owner |
869,565 |
$5.75 |
$5,000,000.00 |
2,758,040 |
N/A |
view |
P* |
2015-02-04 |
2015-02-05 15:59:08.0 |
Tracon Pharmaceuticals, Inc. |
TCON |
MOTT DAVID M |
10% owner |
500,000 |
$10.00 |
$5,000,000.00 |
1,888,470 |
63.80% |
view |